Status:
COMPLETED
Repetitive Transcranial Magnetic Stimulation for Post-Stroke Visual Field Defects
Lead Sponsor:
Ain Shams University
Conditions:
Visual Fields Hemianopsia
Stroke, Ischemic
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Visual field defects (VFD) usually do not show improvement beyond 12 weeks from onset. Plasticity occurs in areas of residual vision (ARV) at the visual field which are the functional counterpart of p...
Detailed Description
Visual functions are widely distributed over large areas within the cerebrum. Secondary to such wide distribution, visual field defects (VFD) are a common outcome of brain insults especially cerebrova...
Eligibility Criteria
Inclusion
- Patients with a brain imaging showing vascular lesion involving visual cortical area
- Duration of at least 3 months.
Exclusion
- Visual field defects of ophthalmologic origin
- Causes of severe visual impairment other than visual field defects
- Drug abuse
- Past history or family history of epilepsy
- Skull bone defects
- Implanted metallic devices
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04021160
Start Date
June 1 2018
End Date
June 5 2020
Last Update
July 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuromodulation Research Lab, Neurology Department, Ain Shams University Hospital
Cairo, Egypt, 11591